Showing 28,021 - 28,040 results of 28,212 for search '(( 19 a decrease ) OR ( 50 ((((ns decrease) OR (nn decrease))) OR (we decrease)) ))', query time: 0.49s Refine Results
  1. 28021

    Image_7_5-Methylcytosine Related LncRNAs Reveal Immune Characteristics, Predict Prognosis and Oncology Treatment Outcome in Lower-Grade Gliomas.tif by Jiheng Zhang (11953919)

    Published 2022
    “…Notably, mutation rate, WHO class II, IDH mutation, 1p/19q co-deletion and MGMT promoter methylation were increased in the low m5CrLS score group. …”
  2. 28022

    Table2_MAP3K1 Variant Causes Hyperactivation of Wnt4/β-Catenin/FOXL2 Signaling Contributing to 46,XY Disorders/Differences of Sex Development.DOCX by Hong Chen (108084)

    Published 2022
    “…Functional assays demonstrated that the MAP3K1<sup>R186G</sup> variant was associated with significantly decreased affinity to ubiquitin (Ub; 43–49%) and increased affinity to RhoA, which was 3.19 ± 0.18 fold, compared to MAP3K1. …”
  3. 28023

    Table1_MAP3K1 Variant Causes Hyperactivation of Wnt4/β-Catenin/FOXL2 Signaling Contributing to 46,XY Disorders/Differences of Sex Development.DOCX by Hong Chen (108084)

    Published 2022
    “…Functional assays demonstrated that the MAP3K1<sup>R186G</sup> variant was associated with significantly decreased affinity to ubiquitin (Ub; 43–49%) and increased affinity to RhoA, which was 3.19 ± 0.18 fold, compared to MAP3K1. …”
  4. 28024

    Compiled data for MULT Allometric Body Mass Index Growth charts by Mariane De Oliveira (19232584)

    Published 2024
    “…However, individuals with missing data (age, weight, height, or socioeconomic indicator), follow-up losses, biologically implausible values, classified as height-for-age z-score below -6 SD or above +6 SD, or BMI-for-age z-score below -5 SD or above +5 SD, measurement errors (children whose height decreased over time), and individuals not meeting the following eligibility criteria were excluded: a) assessed in all three follow-ups for ELANA HS or at least four follow-ups in the other surveys; b) ethnicity classified into one of five categories: Caucasian, Indian, Black, Asian (East or Southeast Asian), or Native Peruvian. …”
  5. 28025

    <i>Cobl</i> KO mice fail to show repair of the dendritic arborization defects caused by MCAO in both layer II/III and layer V neurons of the ipsilateral hemisphere. by Yuanyuan Ji (455424)

    Published 2021
    “…Note that dendritic branching points (<b>E</b>), dendritic terminal points (<b>F</b>), total dendritic tree length (<b>G</b>), and Sholl intersections (<b>H-J</b>) were all decreased at 24 hours after MCAO and that, in contrast to WT animals (<b><a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3001399#pbio.3001399.g005" target="_blank">Fig 5</a></b>), none of these phenotypical parameters recovered during the days after MCAO in <i>Cobl</i> KO mice. …”
  6. 28026

    Data_Sheet_1_The role of meteorological factors on influenza incidence among children in Guangzhou China, 2019–2022.docx by Zhitao Chen (1643053)

    Published 2024
    “…The RR was increased when the relative humidity was below 66% or above 79%, and the highest RR was 7.50 (95% CI: 22.92, 19.25) at 99%. The RR was increased exponentially when the rainfall exceeded 1,625 mm, reaching a maximum value of 2566.29 (95% CI: 21.85, 3558574.07) at the highest rainfall levels. …”
  7. 28027

    Age, language use, and SiN in bilingual adults (Bieber et al., 2025) by Rebecca E. Bieber (18847614)

    Published 2025
    “…<i>Journal of Speech, Language, and Hearing Research</i><i>,</i><i> </i><i>68</i>(4), 2026–2046. <a href="https://doi.org/10.1044/2024_JSLHR-24-00264" target="_blank">https://doi.org/10.1044/2024_JSLHR-24-00264</a></p>…”
  8. 28028

    Table_1_Effect of Supplementing Dairy Goat Diets With Rapeseed Oil or Sunflower Oil on Performance, Milk Composition, Milk Fatty Acid Profile, and in vitro Fermentation Kinetics.XL... by Einar Vargas-Bello-Pérez (12282713)

    Published 2022
    “…Rapeseed oil increased (P < 0.05) C18:2 cis9, trans11 compared to control and sunflower oil (0.37 vs. 0.13 and 0.19 g/100 g). Untargeted milk foodomics revealed slightly elevated (P < 0.05) gluconic acid and decreased hippuric acid (P < 0.05) in the milk of oil-fed goats compared to control. …”
  9. 28029

    Table_2_Effect of Supplementing Dairy Goat Diets With Rapeseed Oil or Sunflower Oil on Performance, Milk Composition, Milk Fatty Acid Profile, and in vitro Fermentation Kinetics.XL... by Einar Vargas-Bello-Pérez (12282713)

    Published 2022
    “…Rapeseed oil increased (P < 0.05) C18:2 cis9, trans11 compared to control and sunflower oil (0.37 vs. 0.13 and 0.19 g/100 g). Untargeted milk foodomics revealed slightly elevated (P < 0.05) gluconic acid and decreased hippuric acid (P < 0.05) in the milk of oil-fed goats compared to control. …”
  10. 28030

    Anterior Ischemic VSD Repair After Failed Percutaneous Device Closure by Rishav Aggarwal (14191566)

    Published 2022
    “…</p> <p>Ventricular septal rupture carries a high risk of mortality with surgical intervention ranging from 60 percent with early intervention and decreasing with time from presentation (3). …”
  11. 28031

    Investigating sperm selection in Y-shredding strains. by Matteo Vitale (13130647)

    Published 2024
    “…<p>(A) Schematic representation of the workflow used to perform sex chromosome counts in the sperm of WT and Y-shredding strains. …”
  12. 28032

    Data_Sheet_1_Changes of Brain Functional Connectivity in End-Stage Renal Disease Patients Receiving Peritoneal Dialysis Without Cognitive Decline.docx by Ting-Yu Chang (463768)

    Published 2021
    “…All participants without a history of cognitive decline received mini-mental status examination (MMSE) and brain 3-T R-fMRI. …”
  13. 28033

    Data Sheet 3_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

    Published 2025
    “…Additional end points included MELD-Na, MELD 3.0, CTP scores, hepatic decompensations, proteinuria, body mass index (BMI), hemoglobin A1c (Hb-A1c), blood glucose (BG).</p>Results<p>At baseline, the two groups were comparable in GFR (SGLT2i: 55.6 ± 1.9 vs. insulin: 58.1 ± 2.1 mL/min/1.73 m², p = 0.37), CKD stage, ARFI-SWV (2.9 ± 0.1 vs. 2.8 ± 0.1 m/s, p = 0.26), MELD-Na, and MELD 3.0. …”
  14. 28034

    Data Sheet 1_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

    Published 2025
    “…Additional end points included MELD-Na, MELD 3.0, CTP scores, hepatic decompensations, proteinuria, body mass index (BMI), hemoglobin A1c (Hb-A1c), blood glucose (BG).</p>Results<p>At baseline, the two groups were comparable in GFR (SGLT2i: 55.6 ± 1.9 vs. insulin: 58.1 ± 2.1 mL/min/1.73 m², p = 0.37), CKD stage, ARFI-SWV (2.9 ± 0.1 vs. 2.8 ± 0.1 m/s, p = 0.26), MELD-Na, and MELD 3.0. …”
  15. 28035

    Data Sheet 8_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

    Published 2025
    “…Additional end points included MELD-Na, MELD 3.0, CTP scores, hepatic decompensations, proteinuria, body mass index (BMI), hemoglobin A1c (Hb-A1c), blood glucose (BG).</p>Results<p>At baseline, the two groups were comparable in GFR (SGLT2i: 55.6 ± 1.9 vs. insulin: 58.1 ± 2.1 mL/min/1.73 m², p = 0.37), CKD stage, ARFI-SWV (2.9 ± 0.1 vs. 2.8 ± 0.1 m/s, p = 0.26), MELD-Na, and MELD 3.0. …”
  16. 28036

    Data Sheet 9_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

    Published 2025
    “…Additional end points included MELD-Na, MELD 3.0, CTP scores, hepatic decompensations, proteinuria, body mass index (BMI), hemoglobin A1c (Hb-A1c), blood glucose (BG).</p>Results<p>At baseline, the two groups were comparable in GFR (SGLT2i: 55.6 ± 1.9 vs. insulin: 58.1 ± 2.1 mL/min/1.73 m², p = 0.37), CKD stage, ARFI-SWV (2.9 ± 0.1 vs. 2.8 ± 0.1 m/s, p = 0.26), MELD-Na, and MELD 3.0. …”
  17. 28037

    Data Sheet 4_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

    Published 2025
    “…Additional end points included MELD-Na, MELD 3.0, CTP scores, hepatic decompensations, proteinuria, body mass index (BMI), hemoglobin A1c (Hb-A1c), blood glucose (BG).</p>Results<p>At baseline, the two groups were comparable in GFR (SGLT2i: 55.6 ± 1.9 vs. insulin: 58.1 ± 2.1 mL/min/1.73 m², p = 0.37), CKD stage, ARFI-SWV (2.9 ± 0.1 vs. 2.8 ± 0.1 m/s, p = 0.26), MELD-Na, and MELD 3.0. …”
  18. 28038

    Data Sheet 7_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

    Published 2025
    “…Additional end points included MELD-Na, MELD 3.0, CTP scores, hepatic decompensations, proteinuria, body mass index (BMI), hemoglobin A1c (Hb-A1c), blood glucose (BG).</p>Results<p>At baseline, the two groups were comparable in GFR (SGLT2i: 55.6 ± 1.9 vs. insulin: 58.1 ± 2.1 mL/min/1.73 m², p = 0.37), CKD stage, ARFI-SWV (2.9 ± 0.1 vs. 2.8 ± 0.1 m/s, p = 0.26), MELD-Na, and MELD 3.0. …”
  19. 28039

    DataSheet_1_Autonomous observations of biogenic N2 in the Eastern Tropical North Pacific using profiling floats equipped with gas tension devices.pdf by Craig L. McNeil (16304715)

    Published 2023
    “…At 17 °N preformed excess-N<sub>2</sub> decreased from approximately 28 to 12 µmol/kg over σ<sub>0 =</sub> 24–27 kg/m<sup>3</sup> with a resulting precision of ±1 µmol N<sub>2</sub>/kg; at 12 °N values were similar except in the potential density range of 25.7< σ<sub>0</sub>< 26.3 where they were lower by 1 µmol N<sub>2</sub>/kg due likely to being composed of different source waters. …”
  20. 28040

    Data Sheet 11_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatoti... by Alessandro Colletta (1509928)

    Published 2025
    “…Additional end points included MELD-Na, MELD 3.0, CTP scores, hepatic decompensations, proteinuria, body mass index (BMI), hemoglobin A1c (Hb-A1c), blood glucose (BG).</p>Results<p>At baseline, the two groups were comparable in GFR (SGLT2i: 55.6 ± 1.9 vs. insulin: 58.1 ± 2.1 mL/min/1.73 m², p = 0.37), CKD stage, ARFI-SWV (2.9 ± 0.1 vs. 2.8 ± 0.1 m/s, p = 0.26), MELD-Na, and MELD 3.0. …”